Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma of Skin Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03553329
What this trial is testing

Study of the Variations of Albumin Level for Patients With Unresecable Stage IIIc or Stage IV Melanoma Treated by Anti BRAF and Anti MEK

Who this might be right for
Unresecable Stage IIIc or IV Melanoma
Poitiers University Hospital 20
Early research (Phase 1)UnknownNCT03353402
What this trial is testing

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

Who this might be right for
Melanoma Stage IvUnresectable Stage III Melanoma
Sheba Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT00436605
What this trial is testing

Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
National Cancer Institute (NCI) 39
Early research (Phase 1)UnknownNCT00037037
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01970527
What this trial is testing

Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
University of Washington 23
Testing effectiveness (Phase 2)Ended earlyNCT00138229
What this trial is testing

Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 6
Testing effectiveness (Phase 2)Study completedNCT00003229
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

Who this might be right for
Melanoma (Skin)
Duke University
Early research (Phase 1)Study completedNCT03980314
What this trial is testing

Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With Stage IIIa/b/c/d or Stage IV Melanoma After Complete Resection

Who this might be right for
Melanoma
Bristol-Myers Squibb 261
Testing effectiveness (Phase 2)Study completedNCT00199901
What this trial is testing

Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma

Who this might be right for
Melanoma
Ludwig Institute for Cancer Research 111
Testing effectiveness (Phase 2)Study completedNCT00019734
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT00002767
What this trial is testing

Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
GlaxoSmithKline 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05608291
What this trial is testing

A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery

Who this might be right for
Melanoma
Regeneron Pharmaceuticals 1,564
Testing effectiveness (Phase 2)Study completedNCT00281541
What this trial is testing

The Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

Who this might be right for
Melanoma
Astellas Pharma Inc 29
Testing effectiveness (Phase 2)Study completedNCT00110994
What this trial is testing

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
CancerMelanoma
Bayer 101
Early research (Phase 1)Study completedNCT00667641
What this trial is testing

Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+6 more
University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Study completedNCT00005057
What this trial is testing

Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
National Human Genome Research Institute (NHGRI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT04139902
What this trial is testing

Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Diwakar Davar 48
Early research (Phase 1)Ended earlyNCT02419495
What this trial is testing

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more
M.D. Anderson Cancer Center 221
Early research (Phase 1)Study completedNCT00003792
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Baylor Health Care System
Testing effectiveness (Phase 2)Study completedNCT00610857
What this trial is testing

Safety and Efficacy of Combination HDI and Anti-CTLA4 for Recurrent Inoperable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Ahmad Tarhini 37
Next Page